Medicare-Funded Pap Testing Has Decreased Invasive Cervical
Cancer Rates
ATLANTA, May 17 (Reuters Health) - The ratio of invasive to in
situ cervical cancer has decreased by about one-third in
Medicare-eligible women since Medicare began to cover Pap smear
testing, Dr. Frederick Montz announced here at the 35th Annual
Meeting of the American Society of Clinical Oncology in Atlanta.
Dr. Montz and colleagues from Johns Hopkins University in
Baltimore, Maryland, examined the California Cancer Registry for
cervical cancer incidence between 1988 and 1990 and between 1991
and 1995. The study periods included the three years prior to,
and the five years after Medicare began paying for Pap smears.
God Bless All,
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
